AG
TMDX icon

Advisor Group’s Transmedics TMDX Stock Holding History

Advisor Group’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$95K Buy
+4,986
New +$91.6K ﹤0.01% 2979

Other funds holding TMDX

ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCP
Sandhill Capital Partners Buffalo, New York $1.16B AUM 12.37% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
ZP
Zimmer Partners New York $4.15B AUM 14.2% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return

Advisor Group's TMDX Position: Q4 2019 in Review

Advisor Group opened a new position in Transmedics (TMDX) in Q4 2019: 4,986 shares worth $95K. The stake represents ﹤0.01% of the portfolio and ranks #2979 among its holdings.

60 funds tracked by Wall St. Rank hold TMDX as of Q4 2019.

  • Advisor Group held 4,986 shares of Transmedics worth $95K as of Q4 2019.
  • Transmedics was a new Advisor Group position in Q4 2019.
  • Transmedics made up ﹤0.01% of Advisor Group's portfolio in Q4 2019, its #2979 holding.
  • 60 funds tracked by Wall St. Rank held Transmedics as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.